摘要
本文报道应用重组组织型纤溶酶原激活剂（ｒｔ－ＰＡ）治疗４２例急性心肌梗塞，对其临床效果进行分析，证实ｒｔ－ＰＡ有缩小梗塞范围，改善心功能，提高患者生活质量和降低病死率的作用。在用药过程中。本组病例未见到严重出血及其他严重副作用。作者对ｒｔ－ＰＡ的给药时机、应用指征及禁忌证作了探讨。
The use of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of 42 Patients of acute myocardial infarction was reported. The clinical effects of rt-PA were analysed. The use of rt-PA could: 1. decrease the size of myocardial infarction; 2.improve left ventricular function; 3. improve live quality, and 4. reduce mortality. No serious hemorrhage or other serious side effects were found during the treatment. Appropriate time of administration, indication and contraindication of rt-PA were discussed.
出处
《中国循环杂志》
CSCD
1994年第1期7-10,共4页
Chinese Circulation Journal
关键词
心肌梗塞
纤溶酶原
激活剂
Acute myocardial infarction (AMI)
Recombinant tissue-type plasminogen activator (rt-PA)
Thrombolytic therapy
